Diffrence in Thromboprofilaksis in Elderly Ostoepenic Hip Fractures According to Mobility Status by Genetic Analysis
Condition(s) studied
Investigational drug(s) / intervention(s)
Gene Expression Analysis: Each subject analysed for SERPİNH1 and ROCK1 gene exppression
Study summary
Hip fracture is a common and severe disease in elderly patients. The question of the study is whether elderly patients with severe osteopenia have significantly lower levels of the collagen-binding protein Hsp47 than relatively mobile patients due to advanced immobility before the fracture, and whether they participants have a similar risk of VTE to the normal population despite having had a hip fracture and surgery.
Eligibility
Primary outcome measure(s)
- HSP 47 — Gene expression analysis will be performed once samples are collected from all participants.
HSP 47 (SERPİNH1, ROCK1) gene expression analysis
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Prof Dr emil Tascıoglu City Hospital | Istanbul | Şişli |
More Saglik Bilimleri Universitesi trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06959017 on ClinicalTrials.gov ↗ ← All trials in Turkey